Flavio Ribichini

Summary

Affiliation: University of Verona
Country: Italy

Publications

  1. doi request reprint Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial
    Flavio Ribichini
    Department of Medicine, University of Verona, Verona, Italy
    Am J Med 124:434-43. 2011
  2. doi request reprint Transcatheter tricuspid valve implantation by femoral approach in trivalvular heart disease
    Flavio Ribichini
    Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy Electronic address
    Am J Cardiol 112:1051-3. 2013
  3. doi request reprint A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease)
    Flavio Ribichini
    Department of Medicine, Universita di Verona, Verona, Italy Electronic address
    JACC Cardiovasc Interv 6:1012-22. 2013
  4. doi request reprint Invasive assessment of renal artery atherosclerotic disease and resistant hypertension before renal sympathetic denervation
    Flavio Ribichini
    Department of Medicine, University of Verona, Verona, Italy
    J Nephrol 26:799-801. 2013
  5. doi request reprint Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Re
    Flavio Ribichini
    Department of Medicine, University of Verona, Verona, Italy
    Eur Heart J 34:1740-8. 2013
  6. doi request reprint A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial
    Flavio Ribichini
    Dipartimento di Scienze Biomediche e Chirurgiche, Universita di Verona, Verona, Italy
    J Cardiovasc Med (Hagerstown) 11:299-309. 2010
  7. ncbi request reprint Neutropenia in patients treated with thienopyridines and high-dose oral prednisone after percutaneous coronary interventions
    Flavio Ribichini
    Division of Cardiology of the University of Verona, Verona, Italy
    J Interv Cardiol 20:209-13. 2007
  8. ncbi request reprint Long-term histological and immunohistochemical findings in human venous aorto-coronary bypass grafts
    Flavio Ribichini
    Division of Cardiology, Department of Biomedical Sciences and Surgery, University of Verona, 37126 Verona, Italy
    Clin Sci (Lond) 114:211-20. 2008
  9. doi request reprint A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study desig
    Flavio Ribichini
    Department of Biomedical Sciences and Surgery, University of Verona, Verona, Italy
    J Cardiovasc Med (Hagerstown) 10:192-9. 2009
  10. doi request reprint Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography
    Flavio Ribichini
    Division of Cardiology, Department of Medicine, University of Verona, Ospedale Civile Maggiore, Verona, Italy
    Am J Med 123:755-63. 2010

Detail Information

Publications48

  1. doi request reprint Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial
    Flavio Ribichini
    Department of Medicine, University of Verona, Verona, Italy
    Am J Med 124:434-43. 2011
    ....
  2. doi request reprint Transcatheter tricuspid valve implantation by femoral approach in trivalvular heart disease
    Flavio Ribichini
    Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy Electronic address
    Am J Cardiol 112:1051-3. 2013
    ..In conclusion, percutaneous valve-in-valve treatment of degenerated bioprostheses is feasible by the transfemoral route and may be of assistance in very selected patients at high surgical risk. ..
  3. doi request reprint A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease)
    Flavio Ribichini
    Department of Medicine, Universita di Verona, Verona, Italy Electronic address
    JACC Cardiovasc Interv 6:1012-22. 2013
    ....
  4. doi request reprint Invasive assessment of renal artery atherosclerotic disease and resistant hypertension before renal sympathetic denervation
    Flavio Ribichini
    Department of Medicine, University of Verona, Verona, Italy
    J Nephrol 26:799-801. 2013
    ....
  5. doi request reprint Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Re
    Flavio Ribichini
    Department of Medicine, University of Verona, Verona, Italy
    Eur Heart J 34:1740-8. 2013
    ..To analyse the clinical outcome at 4 years in patients with coronary artery disease treated with bare metal stents (BMS) vs. BMS and oral prednisone, or drug-eluting stents (DES), all assuming similar adjunctive medical treatment...
  6. doi request reprint A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial
    Flavio Ribichini
    Dipartimento di Scienze Biomediche e Chirurgiche, Universita di Verona, Verona, Italy
    J Cardiovasc Med (Hagerstown) 11:299-309. 2010
    ..The outcome of percutaneous coronary intervention with a second-generation everolimus DES as compared with a paclitaxel DES in patients with MV-CAD has not been established...
  7. ncbi request reprint Neutropenia in patients treated with thienopyridines and high-dose oral prednisone after percutaneous coronary interventions
    Flavio Ribichini
    Division of Cardiology of the University of Verona, Verona, Italy
    J Interv Cardiol 20:209-13. 2007
    ..However, administration of steroids at high dose may raise concerns in terms of applicability and tolerability. Monitoring the occurrence of possible side-effects is therefore mandatory...
  8. ncbi request reprint Long-term histological and immunohistochemical findings in human venous aorto-coronary bypass grafts
    Flavio Ribichini
    Division of Cardiology, Department of Biomedical Sciences and Surgery, University of Verona, 37126 Verona, Italy
    Clin Sci (Lond) 114:211-20. 2008
    ....
  9. doi request reprint A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study desig
    Flavio Ribichini
    Department of Biomedical Sciences and Surgery, University of Verona, Verona, Italy
    J Cardiovasc Med (Hagerstown) 10:192-9. 2009
    ..Such results are however limited by small sample size...
  10. doi request reprint Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography
    Flavio Ribichini
    Division of Cardiology, Department of Medicine, University of Verona, Ospedale Civile Maggiore, Verona, Italy
    Am J Med 123:755-63. 2010
    ..The prognostic value of any early shift of serum creatinine compared with baseline was investigated; such measurement, being a delta, is largely independent of creatinine variations...
  11. doi request reprint Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS)
    Flavio Ribichini
    Department of Medicine, University of Verona, Italy
    EuroIntervention 6:328-35. 2010
    ..To assess the 30-day clinical outcome of endovascular and surgical revascularisation procedures in patients with carotid obstructive disease (COD) and concomitant coronary artery disease (CAD)...
  12. ncbi request reprint Percutaneous treatment of coronary bifurcations: lesion preparation before provisional bare metal stenting and subsequent immunosuppression with oral prednisone. The IMPRESS-Y study
    Flavio Ribichini
    Division of Cardiology of the Università di Verona, Italy
    J Interv Cardiol 20:114-21. 2007
    ..The systemic treatment with oral prednisone after BMS implantation offers good clinical and angiographic results even in the difficult setting of bifurcation lesions...
  13. ncbi request reprint Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis
    Flavio Ribichini
    Division of Cardiology, Universita del Piemonte Orientale, Ospedale Maggiore della Carita, Novara, Italy
    Clin Sci (Lond) 107:381-9. 2004
    ..Other than sample size, clinical variables can modulate the association between ID polymorphism and ISR. Plasma ACE level is a risk factor for ISR, independently of the ID genotype...
  14. ncbi request reprint Long-term results of immunosuppressive oral prednisone after coronary angioplasty in non-diabetic patients with elevated C-reactive protein levels
    Valeria Ferrero
    Division of Cardiology of the Università di Verona, Verona, Italy
    EuroIntervention 5:250-4. 2009
    ..Such studies demonstrated the efficacy of a short course of immunosuppression with oral prednisone after percutaneous coronary intervention (PCI) with bare metal stent (BMS) implantation compared to BMS alone at one year...
  15. ncbi request reprint Intracoronary beta-irradiation for the treatment of de novo lesions: 5-year clinical follow-up of the BetAce randomized trial
    Valeria Ferrero
    Department of Biomedical and Surgical Sciences, Section of Cardiology, University of Verona, Verona, Italy
    Am Heart J 153:398-402. 2007
    ..Despite initial positive results, long-term follow-up has shown a progressive loss of benefit in clinical outcome after beta-irradiation. We report the 5-year follow-up of the BetAce trial...
  16. ncbi request reprint Estrogen receptor-alpha polymorphisms and angiographic outcome after coronary artery stenting
    Valeria Ferrero
    Division of Cardiology, Universita del Piemonte Orientale, Ospedale Maggiore della Carita, Novara, Italy
    Arterioscler Thromb Vasc Biol 23:2223-8. 2003
    ....
  17. doi request reprint Transfemoral Edwards-Novaflex valve implantation in a patient with aorto-iliac endoprosthesis and severely tortuous bilateral external iliac arteries-"Railing track"
    Rajesh M Dandale
    The Department of Medicine, University of Verona, 37126 Verona, Italy
    Cardiovasc Revasc Med 13:203.e5-8. 2012
    ..Transapical TAVI as a first choice was rejected due to severe lung disease. The patient was then treated by Transfemoral TAVI using a dedicated interventional technique that is described in this case-report...
  18. ncbi request reprint Comparison of efficacy and safety of lower-dose to higher-dose oral prednisone after percutaneous coronary interventions (the IMPRESS-LD study)
    Valeria Ferrero
    Division of Cardiology, Universita di Verona, Italy
    Am J Cardiol 99:1082-6. 2007
    ..A 50% dose decrease in oral prednisone, as tested in this study, is less effective than the previously tested HD IMPRESS therapeutic scheme...
  19. doi request reprint Effects of prednisone on biomarkers of tubular damage induced by radiocontrast in interventional cardiology
    Flavio Ribichini
    Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy
    J Nephrol 26:586-93. 2013
    ..Despite the 
severe clinical impact of these complications, there is no optimal therapy for preventing and treating them. We suggest a short course of high-dose steroids as an effective preventive measure...
  20. ncbi request reprint Intracoronary beta-irradiation prevents excessive in-stent neointimal proliferation in de novo lesions of patients with high plasma ACE levels. The BetAce randomized trial
    Flavio Ribichini
    Division of Cardiology, Universita del Piemonte Orientale, Ospedale Maggiore della Carita, Novara, Italy
    Cardiovasc Revasc Med 6:7-13. 2005
    ....
  21. doi request reprint Rationale and design of the Randomized comparison of XiEnce V and Multilink VisioN coronary stents in the sAme muLtivessel patient with chronic kiDnEy disease (RENAL-DES) study
    Fabrizio Tomai
    Division of Cardiology, Department of Cardiovascular Sciences, European Hospital, Rome, Italy
    J Cardiovasc Med (Hagerstown) 11:310-7. 2010
    ..Of note, in patients with CKD, multiple concomitant individual variables may be responsible for neointimal hyperplasia after coronary stenting, thus making the comparison of BMS and DES in different patient groups difficult...
  22. ncbi request reprint Glucocorticoids in the prevention of restenosis after coronary angioplasty: therapeutic potential
    Valeria Ferrero
    Division of Cardiology, University of Verona, Ospedale Civile Maggiore di Verona, Verona, Italy
    Drugs 67:1243-55. 2007
    ..Multicentre randomised studies aimed at defining the efficacy and safety of oral prednisone treatment compared with metallic stents and DES are ongoing, and will become available in upcoming years...
  23. ncbi request reprint Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis
    Flavio Ribichini
    Division of Cardiology of the Università di Verona, Ospedale Civile Maggiore, Verona, Italy
    J Am Coll Cardiol 50:176-85. 2007
    ..Natick, Massachusetts) on neointimal inhibition and vessel healing in an atherosclerotic rabbit model...
  24. ncbi request reprint Steroid-eluting stents in patients with acute coronary syndromes. Angiographic results of DESIRE: Dexamethasone-Eluting Stent Italian REgistry
    Gabriele Pesarini
    aDepartment of Biomedical Sciences and Surgery of the Università di Verona, Verona, Italy
    J Invasive Cardiol 21:86-91. 2009
    ..Steroids have known powerful anti-inflammatory effects. This study was designed to assess the possible antiproliferative action of the Dexamet(R)dexamethasone-loaded stent...
  25. ncbi request reprint Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study
    Fabrizio Tomai
    Division of Cardiology, Department of Cardiovascular Sciences, European Hospital, Via Portuense 700, 00149 Rome, Italy
    Diabetes Care 31:15-9. 2008
    ..In these patients, multiple individual variables may be responsible for neointimal hyperplasia, thus making difficult the comparison of the two drug-eluting stents (DES)...
  26. doi request reprint Is transfemoral aortic valve implantation possible without contrast medium in patients with renal and multiorgan failure?
    Rajesh Dandale
    Universita di Verona, Ospedale Civile Maggiore, Piazzale A Stefani 1, Verona, Italy
    Future Cardiol 8:543-6. 2012
    ....
  27. doi request reprint Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions
    Flavio Ribichini
    Department of Medicine, Division of Cardiology, University of Verona, Verona, Italy
    Clin Chem 58:458-64. 2012
    ..We investigated the diagnostic sensitivities, diagnostic specificities, and variations from baseline for serum creatinine and Cys in CIN...
  28. doi request reprint Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans
    Gabriele Pesarini
    Department of Biomedical Sciences and Surgery, University of Verona, Division of Cardiology, and Laboratory of Clinical Biochemistry and Haematology of the Ospedale Civile Maggiore, Verona, Italy
    Atherosclerosis 211:242-8. 2010
    ..In a sub-group of patients activated NF-kappaB was also evaluated...
  29. doi request reprint Recurrent very late drug-eluting stent thrombosis
    Gabriele Pesarini
    Division of Cardiology of the Ospedale Civile Maggiore, Department of Biomedical Sciences and Surgery of the University of Verona, Verona, Italy
    Cardiovasc Revasc Med 10:130-5. 2009
    ..We report three cases of recurrent very late thrombosis of first generation DESs in middle-aged patients with different degrees of coronary artery disease, presenting with acute myocardial infarction...
  30. doi request reprint Risk stratification in acute coronary syndromes
    Gabriele Pesarini
    Department of Medicine, University of Verona, Verona, Italy
    J Cardiovasc Transl Res 5:1-10. 2012
    ..Indications for CABG in this setting should be evaluated in the context of a local "heart team" or through prespecified protocols in centers without cardiac surgery on site...
  31. doi request reprint Late and very late coronary stent thrombosis: Intravascular ultrasound findings and associations with antiplatelet therapy
    Gabriele Pesarini
    Department of Medicine, Division of Cardiology, University of Verona, Verona, Italy
    Catheter Cardiovasc Interv 82:1056-65. 2013
    ..The aim of this study is to analyze the clinical presentation, angiographic, and intravascular ultrasound (IVUS) findings in patients with late or very late stent thrombosis and the relationship with the antiplatelet regimen...
  32. doi request reprint Percutaneous Impella Recover circulatory support in high-risk coronary angioplasty
    Mario Arieti
    Division of Cardiology of Ospedale Civile Maggiore, Department of Biomedical Sciences and Surgery, University of Verona, Verona, Italy
    Cardiovasc Revasc Med 9:269-74. 2008
    ..5. In our initial experience this device proved to be relatively easy to set up and hemodynamically useful for patients with left ventricular dysfunction and end-stage coronary atherosclerosis...
  33. ncbi request reprint Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting
    Flavio Ribichini
    Division of Cardiology, Universita del Piemonte Orientale, Ospedale Maggiore della Carita, Novara, Italy
    Am J Cardiol 91:154-8. 2003
    ..Such a finding does not negate the known clinical benefits of ACE inhibitors, but it may deserve attention when a patient treated with ACE inhibitors becomes a candidate for stent implantation...
  34. doi request reprint A model of multi-disciplinary approach to the diagnosis and treatment of young patients with cryptogenic stroke and patent foramen ovale
    Sara Mazzucco
    Department of Neurological, Neuropsychological, Morphological and Movement Sciences, Section of Clinical Neurology, University of Verona, Verona, Italy
    Cardiol Young 22:327-34. 2012
    ....
  35. ncbi request reprint Percutaneous angioplasty of the subclavian artery in patients with mammary-coronary bypass grafts
    Flavio Ribichini
    Division of Cardiology, Universita del Piemonte Orientale, Ospedale Maggiore della Carita, Novara, Italy
    J Interv Cardiol 18:39-44. 2005
    ..The clinical presentation, the diagnostic procedures, and the therapeutic approach by means of percutaneous transluminal angioplasty of the subclavian artery are described and discussed...
  36. doi request reprint Influence of 9p21.3 genetic variants on clinical and angiographic outcomes in early-onset myocardial infarction
    Diego Ardissino
    Division of Cardiology, Azienda Ospedaliero Universitaria di Parma, Parma, Italy
    J Am Coll Cardiol 58:426-34. 2011
    ..The purpose of this study was to test whether the 9p21.3 variant rs1333040 influences the occurrence of new cardiovascular events and coronary atherosclerosis progression after early-onset myocardial infarction...
  37. ncbi request reprint Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study)
    Francesco Versaci
    Cattedra di Cardiochirurgia, Divisione di Cardiochirurgia, Universita Tor Vergata, European Hospital, Rome, Italy
    J Am Coll Cardiol 40:1935-42. 2002
    ..This study tested the effect of oral prednisone on clinical and angiographic restenosis rate after successful stent implantation in patients with persistent elevation of systemic markers of inflammation after the procedure...
  38. ncbi request reprint Can ACE Inhibitors Promote Detrimental Vascular Effects After Percutaneous Injury?
    Flavio Ribichini
    Hypertension 40:e5-6; author reply e5-6. 2002
  39. pmc Steroid-eluting stents in patients with acute coronary syndrome: the dexamethasone eluting stent Italian registry
    Flavio Ribichini
    The Università del Piemonte Orientale, Ospedale Maggiore della Carita, Novara, Italy
    Heart 93:598-600. 2007
    ..To assess immediate and mid-term clinical and angiographic outcomes of the dexamethasone drug-eluting stent (D-DES) in patients with acute coronary syndrome (ACS)...
  40. ncbi request reprint Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries
    Valeria Ferrero
    Catheterization Laboratory of the Università del Piemonte Orientale, Ospedale Maggiore della Carita, Novara, Italy
    Am J Cardiol 94:1237-42. 2004
    ....
  41. ncbi request reprint Immunosuppression against restenosis. Efficacy of a radiofrequency guidewire and oral prednisone in achieving and maintaining coronary artery patency after stenting
    Flavio Ribichini
    Cardiac Catheterization Laboratory and Division of Cardiology, Universita del Piemonte Orientale, Novara, Italy
    Cardiovasc Revasc Med 6:124-5. 2005
  42. ncbi request reprint Cellular immunostaining of angiotensin-converting enzyme in human coronary atherosclerotic plaques
    Flavio Ribichini
    Catheterization Laboratory, Ospedale Maggiore della Carita, Universita del Piemonte Orientale, Novara, Italy
    J Am Coll Cardiol 47:1143-9. 2006
    ..The aim of this study was to determine the cellular localization of angiotensin I-converting enzyme (ACE) in the atherosclerotic plaque and its correlation with inflammation and cellular proliferation...
  43. pmc Acute myocardial infarction: reperfusion treatment
    Flavio Ribichini
    Laboratorio di Emodinamica, Universita del Piemonte Orientale, Ospedale Maggiore della Carita, Novara, Italy
    Heart 88:298-305. 2002
  44. ncbi request reprint Haptoglobin phenotype and the risk of restenosis after coronary artery stent implantation
    Ariel Roguin
    The Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Am J Cardiol 89:806-10. 2002
    ....
  45. ncbi request reprint 17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease
    Flavio Airoldi
    Interventional Cardiology Unit, San Raffaele Hospital, Milan, Italy
    Am J Cardiol 96:664-7. 2005
    ..47). The mid-term clinical and angiographic outcomes did not indicate superiority of the 17-beta-E eluting stent over the control PC stent...
  46. ncbi request reprint Trimetazidine improves myocardial perfusion and left ventricular function in ischemic left ventricular dysfunction
    Mauro Feola
    Department of Cardiovascular Diseases, Ospedale S Croce e Carle, Cuneo, Italy
    Clin Nucl Med 29:117-8. 2004
  47. ncbi request reprint Successful surgical treatment of a giant coronary aneurysm communicating with the right atrium
    Andrea Rognoni
    Divisione Clinicizzata di Cardiologia, Azienda Ospedaliera Maggiore della Carita, Novara, Italy
    J Cardiovasc Med (Hagerstown) 8:1061-4. 2007
    ..After 2 years of clinical and echocardiographic control, the patient is symptom-free under conventional medical treatment...
  48. ncbi request reprint Comparison of frequency of insulin resistance after coronary stenting in patients with type 2 diabetes mellitus with versus without coronary restenosis
    Mauro Feola
    Department of Cardiovascular Diseases, Ospedale Santa Croce e Carle, Via Coppino 26, 12100 Cuneo, Italy
    Am J Cardiol 94:777-80. 2004
    ..02), and had smaller K(itt)% (2.9 +/- 1.6%/min vs 3.7 +/- 1.4%/min, p = 0.04) and larger titers of growth hormone (1.36 +/- 1.5 vs 0.68 +/- 0.6 ng/ml, p = 0.02)...